|
Post by magnus123 on May 29, 2020 16:10:45 GMT
This company is in a similar situation as Quotient. They are also waiting for FDA approval for their antibody test, which is already CE Marked since early May. The company sells antibody tests for home usage at $10 per test.
I think that Quotient is definitely a much better company. I would not invest on a long term basis in Biomerica, but the short term speculation could be interesting. I bought a small position at $6.50. The position represents only a fraction of my portfolio in comparison to Quotient, because of the highly risky and speculative characteristics.
Market Cap 73.26M Shares Outstanding 11,305,190
|
|
|
Post by JHam on May 29, 2020 17:10:28 GMT
This company is in a similar situation as Quotient. They are also waiting for FDA approval for their antibody test, which is already CE Marked since early May. The company sells antibody tests for home usage at $10 per test. I think that Quotient is definitely a much better company. I would not invest on a long term basis in Biomerica, but the short term speculation could be interesting. I bought a small position at $6.50. The position represents only a fraction of my portfolio in comparison to Quotient, because of the highly risky and speculative characteristics. Market Cap 73.26M Shares Outstanding 11,305,190 Thanks for the tip. Put it on my watchlist. What’s the accuracy of their test? Funny to see people complaining about how much time it’s taking to get FDA approval. Sounds familiar.
|
|
|
Post by magnus123 on May 29, 2020 17:52:24 GMT
Test data can be found in this document: micromedical.de/de/corona/IgG_IgM-Antibody-Test-Scientific-Data.docxIt's not as good as the Quotient test, but it's not a laboratory test. This test can be used at airports etc. to check, if someone is likely being immune. They are also already selling in Europe and other regions. Someone said that they have contracts with Nato, but i don't have a source for this.
|
|
|
Post by magnus123 on May 29, 2020 17:53:56 GMT
And yes, the ST forum is exactly like Quotients:D
The stock is currently completely dead with no volume. Many people are not patient enough. They should just sell and go away. Same with Quotient.
|
|
|
Post by magnus123 on Jun 8, 2020 14:22:52 GMT
I'm out here. Horrible stock. I hope that no one bought this shit... I use it as tax loss^^
|
|
|
Post by JHam on Jun 8, 2020 18:22:59 GMT
I'm out here. Horrible stock. I hope that no one bought this shit... I use it as tax loss^^ Sorry man. It happens. Hope it didn’t set you back too much.
|
|
|
Post by magnus123 on Jun 9, 2020 11:07:21 GMT
I'm out here. Horrible stock. I hope that no one bought this shit... I use it as tax loss^^ Sorry man. It happens. Hope it didn’t set you back too much. As i said in the first post, i bought only a small, speculative position. It's of course never nice to lose money, but no one is always successful. If they get the EUA, the stock would explode, but i have some doubts, given that their test is a finger prick test. Those finger prick tests are prohibited in the UK for example and that is definitely a red flag signal for me here.
|
|
|
Post by JHam on Jun 10, 2020 18:16:35 GMT
Sorry man. It happens. Hope it didn’t set you back too much. As i said in the first post, i bought only a small, speculative position. It's of course never nice to lose money, but no one is always successful. If they get the EUA, the stock would explode, but i have some doubts, given that their test is a finger prick test. Those finger prick tests are prohibited in the UK for example and that is definitely a red flag signal for me here. Funny how BMRA has been shadowing QTNT’s pps action since yesterday.
|
|
|
Post by magnus123 on Jun 11, 2020 16:07:07 GMT
Looks like this pattern is broken up now. Biomerica -9% and QTNT only -2%
|
|